Its net profit rose 12% to RON8.04 million, compared with RON7.2 million in 2013, according to the company’s preliminary report.
Ropharma estimated a 5% sales increase for 2014, at RON430 million, and a 25% higher profit, at RON9 million.
The company’s debts fell 28% last year to RON163.4 million.
Ropharma has two production units, in Targu Mures and Chisinau, where it makes nutritional supplements and medicines. The distribution company also has five warehouses and an own drugstore network of 115 units.
Businessman Mihai Miron indirectly owns 31.78% of Ropharma. He controls 14.12% via Rimia Investments and 17.66% via ADD Pharmaceuticals, both registered in Cyprus.
Monday, Ropharma closed down 1.12% at RON0.3429 a share in Bucharest, valuing the company at RON174.74 million. (EUR1=RON4.4407)